Analysis of loss of heterozygsity effect on thyroid tumor with oxyphilia cell locus in familial non medullary thyroid carcinoma in Iranian families

Indian Journal of Human Genetics

Volumn 18, Issue 3, 2012, Pages 340-343

  Shirazi, Hasti Atashi ^a   Hedayati, Mehdi ^a   Daneshpour, Maryam Sadat ^a   Shafiee, Abdollah ^b   Azizi, Fereidoun ^a,c,d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MILAD HOSPITAL   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Familial non medullary thyroid carcinoma; Iran; Loss of heterozygosis; Thyroid tumor with oxyphilia cell

Indexed keywords

GENOMIC DNA;

ARTICLE; DNA EXTRACTION; FAMILIAL CANCER; FAMILIAL NON MEDULLARY THYROID CARCINOMA; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; IRAN; MAJOR CLINICAL STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 84875717831     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.107989     Document Type: Article

References (11)

1. Bast R., et al. Holland-Frei Cancer Medicine. 5th ed. Hamilton (ON): BC Decker; 2000.
2. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 1998;63:1743-8.
3. Ward LS, Brenta G, Medvedovic M, Fagin JA. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab 1998;83:525-30.
4. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar DE, et al. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: Exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 1999;84:2157-62.
5. Gasparre G, Bonora E, Tallini G, Romeo G. Molecular features of thyroid oncocytic tumors. Mol Cell Endocrinol 2010;321:67-76.
6. Malchoff CD, Malchoff DM. The genetics of hereditary nonmedullary thyroid carcinoma. J Clin Endocrinol Metab 2002;87:2455-9.
7. Pal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, et al. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: A hospital-based study. J Clin Endocrinol Metab 2001;86:5307-12.
8. Prazeres HJ, Rodrigues F, Soares P, Naidenov P, Figueiredo P, Campos B, et al. Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 2008;7:141-9.
9. Malchoff CD, Malchoff DM. Familial nonmedullary thyroid carcinoma. Cancer Control 2006;13:106-10.
10. Bonora E, Tallini G, Romeo G. Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies. J Oncol 2010;2010:385206.
11. Grebe SK, McIver B, Hay ID, Wu PS, Maciel LM, Drabkin HA, et al. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab 1997;82:3684-91.